Scholars Central

Conference abstractPublished 24 Dec 2015

Methods for maximally precise individualization of drug therapy

Authors: Ayman M Noreddin, Chapman University School of Pharmacy, USA

Roger Jelliffe, USC School of Medicine, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This workshop is intended for physicians, pharmacists, clinical toxicologists and biomedical scientists with an interest in Therapeutic Drug Monitoring (TDM), and in optimal individualization of drug therapy for best patient care. Prior experience in clinical pharmacokinetics will be an advantage. Participants will be introduced to the USC Best dose clinical software, which will be compared and contrasted with other approaches. This library of software tools now provides maximally precise methods for clinical therapeutic drug management. Objectives and Expectations: 1. Describe the General approach to Target-Oriented, Model Based, and Individualized Drug Therapy. 2. Discuss the Clinical capabilities of Nonparametric Population Modeling, and compare it with similar parametric approaches. 3. Explain the need for using assay standard deviation rather than CV% in reporting lab errors. 4. Explain Multiple Model, maximally precise, Dosage Design. 5. Describe the Interacting Multiple Model (IMM) method of sequential Bayesian individualization of Pharmacokinetic Models, and when and how to use them. 6. Summarize the features of models of bacterial growth and kill 7. Explain the new approaches to optimize TDM protocols for best learning about the patient while treating him/her at the same time. 8. Discuss improved outcomes using Bayesian adaptive control. 9. Apply these concepts to optimize practical therapy with Aminoglycosides, Vancomycin, Digoxin, and other drugs. Individualized Drug Therapy: Example of Antimicrobial Therapy âÂ?Â?Dr. Noreddin Tools for Optimizing Individualized Drug Therapy - Dr. Jelliffe Tool #1 âÂ?Â? Nonparametric Population Pharmacokinetic/dynamic Models Tool #2 âÂ?Â? Multiple Model (MM) Dosage Design Tool #3 âÂ?Â? Correct Description of assay errors âÂ?Â? reciprocal of assay variance, Not CV% Tool #4 âÂ?Â? Estimating Creatinine Clearance from changing, not stable, Serum creatinine measurements Tool #5 âÂ?Â? Optimizing protocols for Therapeutic Drug Monitoring Tool #6 âÂ?Â? Optimizing Individualized therapy of acutely ill and Unstable ICU patients. Improved outcomes with Individualized Therapy âÂ?Â? Dr. Jelliffe, Dr. Noreddin

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ayman M Noreddin”
  • BylineArticles whose byline prints “Chapman University School of Pharmacy”
  • BylineArticles whose byline prints “USA”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels